Brucellosis in San Diego: Epidemiology and species-related differences in acute clinical presentations

Medicine

Volumn 84, Issue 3, 2005, Pages 174-187

  Troy, Stephanie B ^b,c   Rickman, Leland S ^b   Davis, Charles E ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DAIRY PRODUCT; ETHNIC DIFFERENCE; FEMALE; HEPATOMEGALY; HISPANIC; HUMAN; INCUBATION TIME; INFANT; LIVER DYSFUNCTION; MALE; MEXICO; PANCYTOPENIA; PASTEURIZATION; PRIORITY JOURNAL; RADIOMETRY; SEX DIFFERENCE; SPECIES COMPARISON; SPLENOMEGALY; THROMBOCYTOPENIA; UNITED STATES; ZOONOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CALIFORNIA; CHILD, PRESCHOOL; DAIRY PRODUCTS; FEMALE; HISPANIC AMERICANS; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SPECIES SPECIFICITY; TRAVEL; ZOONOSES;

EID: 18744399840     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000165659.20988.25     Document Type: Article

References (83)

1. Agalar C, Usubutun S, Turkyilmaz R. Ciprofloxacin and rifampin versus doxycycline and rifampin in the treatment of brucellosis. Eur J Clin Microbiol Infect Dis. 1999;18:535-538.
2. Akdeniz H, Irmak H, Anlar O, Demiroz AP. Central nervous system brucellosis: presentation, diagnosis, and treatment. J Infect. 1998;36:297-301.
3. Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gur D. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother. 1993;37:1831-1834.
4. Al-Eissa Y, Al-Zamil F, Al-Mugerein M, Al-Rasheed S, Al-Sanie A, Al-Mazyad. Childhood brucellosis: a deceptive infectious disease. Scand J Infect Dis. 1991;23:129-133.
5. Al-Eissa Y. Probable breast-milk borne brucellosis in a young infant. Ann Trop Paediatr. 1990;10:305-307.
6. Ariza J, Corredoira J, Pallares R, Viladrich PF, Rufi G, Pujol M, Gudiol F. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis. 1995;20:1241-1249.
7. Ariza J, Gudiol F, Pallares R, Viladrich PF, Rufi G, Corredoira J, Miravetlles MR. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. Ann Intern Med. 1992;117:25-30.
8. Ariza J, Gudiol F, Valverde J. Pallares R, Fernandez-Viladrich P, Rufi G, Espadaler L, Fernandez-Nogues F. Brucellar spondylitis: a detailed analysis based on current findings. Rev Infect Dis. 1985;7:656-664.
9. Ariza J, Pigrau C, Canas C, Marron A, Martinez F, Almirante B, Corredoira JM, Casanova A, Fabregat J, Pahissa A. Current understanding and management of chronic hepatosplenic suppurative brucellosis. Clin Infect Dis. 2001;32:1024-1033.
10. Bannatyne RM, Jackson MC, Memish Z. Rapid diagnosis of Brucella bacteremia by using the Bactec 9240 system. J Clin Microbiol. 1997;35:2673-2674.
11. Bellamy RJ, Freedman AR. Bioterrorism. Q J Med. 2001;94:227-234.
12. Braude AI. Studies in the pathology and pathogenesis of experimental brucellosis. I. A comparison of the pathogenicity of Brucella abortus, Brucella melitensis, and Brucella suis for guinea pigs. J Infect Dis. 1951;89:76-86.
13. Buchanan TM, Faber LC, Feldman RA. Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part 1. Clinical features and therapy. Medicine (Baltimore). 1974;53:403-413.
14. Campos MA, Rosinha GMS, Almeida IC, Salgueiro XS, Jarvis BW, Splitter GA, Qureshi N, Bruna-Romero O, Gazinelli RT, Oliveira SC. Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect Immun. 2004;72:176-186.
15. Capasso L. Bacteria in two-millennia-old cheese, and related epizoonoses in Roman populations. J Infect. 2002;45:122-127.
16. Castaneda MR. A practical method for routine blood culture in brucellosis. Proc Soc Exp Biol Med. 1947;64:114.
17. Centers for Disease Control and Prevention. Summary of Notifiable Diseases - United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;51:1-84.
18. Chomel BB, De Bess EE, Mangiamele DM, Reilly KF, Farver TB, Sun RK, Barrett LR. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis. 1994;170:1216-1223.
19. Cockerill FR III, Wilson JW, Vetter EA, Goodman KM, Torgerson CA, Harmsen WS, Schleck CD, Ilstrup DM, Washington JA II, Wilson WR. Optimal testing parameters for blood cultures. Clin Infect Dis. 2004;38:1724-1730.
20. Colmenero J de D, Queipo-Ortuno MI, Reguera JM, Suarez-Munoz MA, Martin-Carballino S, Morata P. Chronic hepatosplenic abscesses in brucellosis: clinico-therapeutic features and molecular diagnostic approach. Diagn Microbiol Infect Dis. 2002;42:159-167.
21. Colmenero JD, Reguera JM, Martos F, Sanchez-De-Mora D, Delgado M, Causse M, Martin-Farfan A, Juarez C. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore). 1996;75:195-211.
22. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis. 1997;3:213-221.
23. Crosby S, Llosa L, Miro Quesada M, Carillo C, Gotuzzo E. Hematologic changes in brucellosis. J Infect Dis. 1984;150:419-424.
24. Doyle TJ, Bryan RT. Infectious disease morbidity in the US region bordering Mexico, 1990-1998. J Infect Dis. 2000;182:1503-1510.
25. Feiz J, Sabbaghian H, Miralai M. Brucellosis due to B. melitensis in children: clinical and epidemiologic observations on 95 patients studied in central Iran. Clin Pediatr. 1978;17:904-907.
26. Fiori PL, Mastrandrea S, Rappelli P, Cappuccinelli P. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol. 2000;38:2005-2006.
27. Fosgate GT, Carpenter TE, Chomel BB, Case JT, DeBess EE, Reilly KF. Time-space clustering of human brucellosis, California, 1973-1992. Emerg Infect Dis. 2002;8:672-678.
28. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Parlin JA, Christopher GW, Eitzen EM Jr. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997;278:399-411.
29. Gonzalez-Gay M, Garcia-Porrua C, Ibanez D, Garcia-Pais M. Osteoarticular complications of brucellosis in an Atlantic area of Spain. J Rheumatol. 1999;26:141-145.
30. Gottesman G, Vanunu D, Maayan MC, Lang R, Uziel Y, Sagi H, Wolach B. Childhood brucellosis in Israel. Pediatr Infect Dis J. 1996;15:610-615.
31. Gotuzzo E, Alarcon GS, Bocanegra TS, Carrillo C, Guerra JC, Rolando I, Espinoza LR. Articular involvement in human brucellosis: a retrospective analysis of 304 cases. Semin Arthritis Rheum. 1982;12:245-255.
32. Greenblatt J, Hopkins C, Barry A, DeMaria A. Suspected brucellosis case prompts investigation of possible bioterrorism-related activity - New Hampshire and Massachusetts, 1999. MMWR Morb Mortal Wkly Rep. 2000;49:509-512.
33. Kaufmann AF, Fox MD, Boyce JM, Anderson DC, Potter ME, Martone WJ, Patton CM. Airborne spread of brucellosis. Ann NY Acad Sci. 1980;353:105-114.
34. Khan MY, Mah MW, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis. 2001;32:1172-1177.
35. Khateeb MI, Araj GF, Majeed SA, Lulu AR. Brucella arthritis: a study of 96 cases in Kuwait. Ann Rheum Dis. 1990;49:994-998.
36. Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev. 2003;16:65-78.
37. Kochar DK, Kumawat BL, Agarwal N, Shubhakaran, Aseri S, Sharma BV, Rastogi A. Meningoencephalitis in brucellosis. Neurol India. 2000;48:170-173.
38. Leggiadro RJ. The threat of biological terrorism: a public health and infection control reality. Infect Control Hosp Epidemiol. 2000;21:53-56.
39. Lubani MM, Dudin KI, Sharda DC, Abu Sinna NM, Al-Shab T, Al-Refe' ai AA, Labani SM, Nasrallah A. Neonatal brucellosis. Eur J Pediatr. 1988;147:520-522.
40. Lubani MM, Dudin KI, Sharda DC, Mana Ndher DS, Araj GF, Hafez HA, Al-Saleh OA, Helin I, Salhi MM. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J. 1989;8:75-78.
41. Malik GM. A clinical study of brucellosis in adults in the Asir region of southern Saudi Arabia. Am J Trop Med Hyg. 1997;56:375-377.
42. Martin-Moreno S, Soto-Guzman O, Berndaldo-de Quiros J, Reverte-Cejudo D, Bascones-Casas C. Pancytopenia due to hemophagocytosis in patients with brucellosis: a report of four cases. J Infect Dis. 1983;147:445-449.
43. McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis. 1992;15:582-590.
44. Memish Z, Mah MW, Al Mahmoud S, Al Shaalan M, Khan MY. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J Infect. 2000;40:59-63.
45. Miranda RT, Gimeno AE, Rodriquez TF, de Arriba JJ, Olmo DG, Solara J. Acute cholecystitis caused by Brucella melitensis: case report and review. J Infect. 2001;42:77-78.
46. Montejo JM, Aberola I, Glez-Zarate P, Alvarez A, Alonso J, Canovas A, Aguirre C. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis. 1993;16:671-676.
47. Mousa AM, Bahar RH, Araj GF, Koshy TS, Muhtaseb SA, al-Mudallal DS, Marafie AA. Neurological complications of brucella spondylitis. Acta Neurol Scand. 1990;81:16-23.
48. Mousa AM, Muhtaseb SA, Almudallal DS, Khodeir SM, Marafie AA. Osteoarticular complications of brucellosis: a study of 169 cases. Rev Infect Dis. 1987;9:531-543.
49. Navarro-Martinez A, Solera J, Corredoira J, Beato JL, Martinez-Alfaro E, Atienzar M, Ariza J. Epididymoorchitis due to Brucella melitensis: a retrospective study of 59 patients. Clin Infect Dis. 2001;33:2017-2022.
50. Noah DL, Huebner KD, Darling RG, Waeckerle JF. The history and threat of biological warfare and terrorism. Emerg Med Clin North Am. 2002;20:255-271.
51. Omar FZ, Zuberi S, Minns RA. Neurobrucellosis in childhood: six new cases and a review of the literature. Dev Med Child Neurol. 1997;39:762-765.
52. Palanduz A, Palanduz S, Guler K, Guler N. Brucellosis in a mother and her young infant: probable transmission by breast milk. Int J Infect Dis. 2000;4:55-56.
53. Reguera JM, Alarcon A, Miralles F, Pachon J, Juarez C, Colmenero JD. Brucella endocarditis: clinical, diagnostic and therapeutic approach. Eur J Clin Microbiol Infect Dis. 2003;22:647-650.
54. Reitman CA, Watters WC III. Spinal brucellosis: case report in the United States. Spine. 2002;27:E250-E252.
55. Reuters. Ex-UN inspector says Iraq had Brucella biological agent. Gulf News Online Edition. Washington DC, February 3, 2001. Availabie at: http://www.gulf-news.com/Articles/news.asp?ArticleID=8646.
56. Robichaud S, Libman N, Behr M, Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis. 2004;38:e119-122.
57. Rosenbloom M, Leikin JB, Vogel SN, Chaudry ZA. Biological and chemical agents: a brief synopsis. Am J Ther. 2002;9:5-14.
58. Ruiz J, Lorente I, Perez J, Simarro E, Martinez-Campos L. Diagnosis of brucellosis by using blood cultures. J Clin Microbiol. 1997;35:2417-2418.
59. Schirger A, Nichols DR, Martin WJ, Wellman WE, Weed LA. Brucellosis: experience with 224 patients. Ann Intern Med. 1960;52:827-837.
60. Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev. 1995;8:389-405.
61. Shapiro D, Wong J. Brucellosis. In: The Manual of Clinical Microbiology. Murray PR, Baron EJ, Pfaller MF, Tenover FC, Yolken RH, eds. 7th ed. Washington, DC: ASM Press, 1999:625-632.
62. Solera J, Martinez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs. 1997;53:245-256.
63. Solera J, Rodriquez-Zapata M, Geijo P, Largo J, Paulino J, Saez L, Martinez-Alfaro E, Sanchez L, Sepulveda MA, Ruiz-Ribo MD. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chemother. 1995;39:2061-2067.
64. Spink WW. The Nature of Brucellosis. Minneapolis: University of Minnesota Press, 1956.
65. Spink WW. Some biologic and clinical problems related to intracellular parasitism in brucellosis. N Engl J Med. 1952;247:603-610.
66. Staszkiewicz J, Lewis CM, Colville J, Zervos M, Band J. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol. 1991;29:287-290.
67. Varon E, Cohen R, Bouhanna CA, Canet J, Janaud JC, Geslin P. Brucellosis in a 3 month-old infant. Arch Fr Pediatr. 1990;47:587-590.
68. White AC, Atmar RL. Infections in hispanic immigrants. Clin Infect Dis. 2002;34:1627-1632.
69. Wise RI. Brucellosis in the United States: past, present, and future. JAMA. 1980;244:2318-2322.
70. Yagupsky P, Peled N, Press J, Abramson O, Abu-Rashid M. Comparison of BACTEC 9240 peds plus medium and isolator 1.5 microbial tube for detection of Brucella melitensis from blood cultures. J Clin Microbiol. 1997;35:1382-1384.
71. Yagupsky P, Peled N, Press J, Abu-Rashid M, Abrahamson O. Rapid detection of Brucella melitensis from blood cultures by a commercial system. Eur J Clin Microbiol Infect Dis. 1997;16:605-607.
72. Yagupsky P, Peled N, Riesenberg K, Banai M. Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area. Scand J Infect Dis. 2000;32:31-35.
73. Yagupsky P. Detection of Brucellae in blood cultures. J Clin Microbiol. 1999;37:3437-3442.
74. Ying W, Nguyen MQ, Jahre JA. Brucella canis endocarditis: case report. Clin Infect Dis. 1999;29:1593-1594.
75. Young EJ. An overview of human brucellosis. Clin Infect Dis. 1995;21:283-290.
76. Young EJ, Borchert M, Kretzer FL, Musher DM. Phagocytosis and killing of Brucella by polymorphonuclear leucocytes. J Infect Dis. 1985;151:682-690.
77. Young EJ. Brucella melitensis hepatitis: the absence of granulomas. Ann Intern Med. 1979;91:414-415.
78. Young EJ. Chapter 215. Brucella species. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R, eds. 5th ed, Vol. 2. Philadelphia: Churchill Livingstone; 2000:2386-2393.
79. Young EJ, Corbel MJ. Brucellosis: Clinical and Laboratory Aspects. Boca Raton, FL: CRC Press; 1989.
80. Young EJ, Gomez CI, Yawn DH, Musher DM. Comparison of Brucella abortus and Brucella melitensis infections of mice and their effect on acquired cellular resistance. Infect Immun. 1979;26:680-685.
81. Young EJ. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis. 1991;13:359-372.
82. Young EJ, Tarry A, Genta RM, Ayden N, Gotuzzo E. Thrombocytopenia purpura associated with brucellosis: report of two cases and literature review. Clin Infect Dis. 2000;31:904-909.
83. Young EJ. Brucellosis outbreak attributed to ingestion of unpasteurized goat cheese. Arch Intern Med. 1975;135:240-243.